COVID-19 Impact on Services
December 20, 2020
Your safety and that of our staff remain our constant priority.
Click here for the latest COVID-19 information for Nucleus.
We continue to provide services to consumers during the COVID-19 pandemic. We want to advise you that a service disruption may occur if we do not have the required staff to provide all services. If services are disrupted, you will be notified and we will need to prioritize essential services to ensure consumer safety. If you have a back-up plan, we would ask that you be ready to activate it. If a disruption in services occurs as a result of the changing situation, Nucleus will notify each consumer of these changes.
COVID-19 Prevention
There are simple, but very effective things you can do to help protect yourself and others from COVID-19:
- Wash your hands
- Don’t touch your face
- Stay home unless going out is essential
- Avoid physical contact unless it is essential; maintain a distance of 2 metres or 6 feet from others
- Regularly clean high touch surfaces, such as door handles, phones, remotes
- Make sure to strictly follow instructions if you or a family member has been told to self-isolate at home including not leaving the house
- Stay home if you are sick
Public Health Resources
Please visit your public health website for updates on the COVID-19 situation:
Latest from Nucleus
Webinar on November 13, 2023. An Update on What Everyone Needs to Know to Enable Healthy Ageing.
Changes to Masking Requirements for Our Staff Effective October 2, 2023.
Public Health Updates to Masking Requirements that impact Nucleus care delivery effective August 1, 2023. *Updates as of October 2, 2023: Nucleus returns to mandatory masks for staff.
Vaccination Update: Bivalent COVID-19 Booster Dose Availability
Rising COVID cases present significant challenges to the healthcare system.
Effective November 30, 2021 all Nucleus staff, volunteers and contractors (including agency staff) must be fully vaccinated to be scheduled for work and deliver care. This is to ensure both client, staff and community safety against COVID-19.
Since the pandemic began, Nucleus has delivered over 200,000 visits without any transmission of COVID.
Your safety and that of our staff remain our constant priority.
Dr. David Burt is an immunologist with more than 30 years research experience in universities and vaccine companies. He has led scientific teams involved in the development of vaccines against various infectious diseases including influenza and SARS. He received his Ph.D. in Immunology from the University of Birmingham, UK and a BSc. in Biological chemistry from Essex University, UK. David received the African Canadian Achievement Award in Science in 1997 and the Harry Jerome Award for Health Sciences in 2006 for his professional work and promotion of science in the community. Currently, Dr. Burt is President of D. S. Burt, R&D Consulting, offering independent consulting advice in biotechnology and vaccine research and development. Dr. Burt is a member of the City of Toronto’s Black Scientist Task Force on Vaccine Equity whose mandate is to engage the communities most impacted by the pandemic around issues related to COVID-19 and vaccines.
Dear Valued Nucleus Consumer, I'd like to take this opportunity to introduce myself and let you know how you can get a hold of me. My name is Laura Salisbury and I am the new Chief Executive Officer at Nucleus Independent Living. I have discovered many new things in my first 60 days here, including ideas on how we can better communicate with one another. One of our top priorities is to ensure your safety and to create a positive experience with every visit. I want to keep you informed on all the ways we are working to achieve that every time. A few highlights I would like to share so far are ...
